These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35878004)

  • 1. Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells.
    Cheng Y; Clark AE; Zhou J; He T; Li Y; Borum RM; Creyer MN; Xu M; Jin Z; Zhou J; Yim W; Wu Z; Fajtová P; O'Donoghue AJ; Carlin AF; Jokerst JV
    ACS Nano; 2022 Aug; 16(8):12305-12317. PubMed ID: 35878004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor Screening.
    Cheng Y; Clark AE; Yim W; Borum RM; Chang YC; Jin Z; He T; Carlin AF; Jokerst JV
    Anal Chem; 2023 Feb; 95(7):3789-3798. PubMed ID: 36753444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors.
    Huff S; Kummetha IR; Tiwari SK; Huante MB; Clark AE; Wang S; Bray W; Smith D; Carlin AF; Endsley M; Rana TM
    J Med Chem; 2022 Feb; 65(4):2866-2879. PubMed ID: 34570513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Self-Immolative Fluorescent Probe for Selective Detection of SARS-CoV-2 Main Protease.
    Xu M; Zhou J; Cheng Y; Jin Z; Clark AE; He T; Yim W; Li Y; Chang YC; Wu Z; Fajtová P; O'Donoghue AJ; Carlin AF; Todd MD; Jokerst JV
    Anal Chem; 2022 Aug; 94(34):11728-11733. PubMed ID: 35973073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV and anti-HCV small molecule protease inhibitors in-silico repurposing against SARS-CoV-2 M
    Sultan A; Ali R; Ishrat R; Ali S
    J Biomol Struct Dyn; 2022; 40(23):12848-12862. PubMed ID: 34569411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of M Protease Inhibitors Encoded by SARS-CoV-2.
    Hung HC; Ke YY; Huang SY; Huang PN; Kung YA; Chang TY; Yen KJ; Peng TT; Chang SE; Huang CT; Tsai YR; Wu SH; Lee SJ; Lin JH; Liu BS; Sung WC; Shih SR; Chen CT; Hsu JT
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32669265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 M
    Zhang K; Wang T; Li M; Liu M; Tang H; Wang L; Ye K; Yang J; Jiang S; Xiao Y; Xie Y; Lu M; Zhang X
    Eur J Med Chem; 2023 Sep; 257():115487. PubMed ID: 37257212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.
    Anirudhan V; Lee H; Cheng H; Cooper L; Rong L
    J Med Virol; 2021 May; 93(5):2722-2734. PubMed ID: 33475167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved SARS-CoV-2 main protease high-throughput screening assay using a 5-carboxyfluorescein substrate.
    Legare S; Heide F; Bailey-Elkin BA; Stetefeld J
    J Biol Chem; 2022 Apr; 298(4):101739. PubMed ID: 35182525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3.
    Griffin JWD
    J Struct Biol; 2020 Sep; 211(3):107575. PubMed ID: 32653646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis.
    Xiao T; Wei Y; Cui M; Li X; Ruan H; Zhang L; Bao J; Ren S; Gao D; Wang M; Sun R; Li M; Lin J; Li D; Yang C; Zhou H
    Phytomedicine; 2021 Oct; 91():153704. PubMed ID: 34419736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
    Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC
    J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of SARS-CoV 3C-like protease with baicalein.
    Feng J; Li D; Zhang J; Yin X; Li J
    Biochem Biophys Res Commun; 2022 Jun; 611():190-194. PubMed ID: 35490659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 M
    Arutyunova E; Khan MB; Fischer C; Lu J; Lamer T; Vuong W; van Belkum MJ; McKay RT; Tyrrell DL; Vederas JC; Young HS; Lemieux MJ
    J Mol Biol; 2021 Jun; 433(13):167003. PubMed ID: 33895266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
    Vuong W; Khan MB; Fischer C; Arutyunova E; Lamer T; Shields J; Saffran HA; McKay RT; van Belkum MJ; Joyce MA; Young HS; Tyrrell DL; Vederas JC; Lemieux MJ
    Nat Commun; 2020 Aug; 11(1):4282. PubMed ID: 32855413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.